Edesa Biotech Inc reports results for the quarter ended in June - Earnings Summary

Edesa Biotech

10/08/2023 14:31

* Edesa Biotech Inc  EDSA.OQ  reported a quarterly adjusted
loss
of 10 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 17 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Edesa Biotech Inc's reported EPS for the quarter was a
loss
of 10 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Edesa Biotech Inc shares had risen by 13.1% this
quarter and
lost 57.5% so far this year.
    * The company reported a quarterly loss of $1.99 million.
    * Wall Street's median 12-month price target for Edesa
Biotech Inc
is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.17          -0.10          Beat
 Mar. 31 2023      -0.17          -0.12          Beat
 Dec. 31 2022      -0.19          -0.13          Beat
 Sep. 30 2022      -0.39          -0.02          Beat